GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (NZSE:EBO) » Definitions » 10-Year RORE %

Ebos Group (NZSE:EBO) 10-Year RORE % : 25.51% (As of Dec. 2023)


View and export this data going back to 1960. Start your Free Trial

What is Ebos Group 10-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Ebos Group's 10-Year RORE % for the quarter that ended in Dec. 2023 was 25.51%.

The industry rank for Ebos Group's 10-Year RORE % or its related term are showing as below:

NZSE:EBO's 10-Year RORE % is ranked better than
78.95% of 57 companies
in the Medical Distribution industry
Industry Median: 8.7 vs NZSE:EBO: 25.51

Ebos Group 10-Year RORE % Historical Data

The historical data trend for Ebos Group's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ebos Group 10-Year RORE % Chart

Ebos Group Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
10-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.11 20.29 26.42 24.98 25.64

Ebos Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.52 24.98 23.70 25.64 25.51

Competitive Comparison of Ebos Group's 10-Year RORE %

For the Medical Distribution subindustry, Ebos Group's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ebos Group's 10-Year RORE % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ebos Group's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where Ebos Group's 10-Year RORE % falls into.



Ebos Group 10-Year RORE % Calculation

Ebos Group's 10-Year RORE % for the quarter that ended in Dec. 2023 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( 1.466-0.65 )/( 10.414-7.215 )
=0.816/3.199
=25.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2023 and 10-year before.


Ebos Group  (NZSE:EBO) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Ebos Group 10-Year RORE % Related Terms

Thank you for viewing the detailed overview of Ebos Group's 10-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ebos Group (NZSE:EBO) Business Description

Traded in Other Exchanges
Address
108 Wrights Road, P.O. Box 411, Christchurch, STL, NZL, 8024
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group (NZSE:EBO) Headlines

No Headlines